Get startedLog in
    Picture of Mega Genomics logo

    6667 — Mega Genomics Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Mega Genomics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line38.394.995.9-21.436.2
    Depreciation
    Amortisation
    Non-Cash Items25.414.89.7215.2-10.8
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-40.5-20.9-88.9-15.9123
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities37.310330.6-6.91164
    Capital Expenditures-0.761-1.04-4.42-5.19-36.1
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items18.4-302.712.632.34
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities17.7-31.1-1.71-2.56-33.8
    Financing Cash Flow Items-3.0598.1-216-18.46.94
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-20.384.12.62158-12.9
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash34.715630.6161118